Steriline
Steriline’s significant growth in the Indian market will now drive Steriline Asia to expand further

Steriline, a company specializing in the production of complete aseptic filling lines for injectables and ophthalmic products for global pharmaceutical companies, will again be present this year with its own stand (No. 10.D23, subevent P-MEC) at CPHI & PMEC India. This major pharma trade show will be held in the India Expo Centre of Greater Noida, near Delhi NCR, from 25 to 27 November 2025.

Steriline trades its products worldwide, with more than 90% of its turnover originating from international exports. In addition to the market in Europe, where the company was founded and is still headquartered, India is a particularly important market, with turnover more than 15% above the total sales over the last three years.

“Participating in PMEC India is a mandatory step for Steriline,” says Federico Fumagalli, CSO at Steriline. “I am proud we can announce, at this major event, that we have reached one hundred full line installations in India, an important milestone that shows how the tremendous work we have done, and continue to do, in Asia and especially in the Indian continent, has paid off.”

Steriline’s significant growth in the Indian market will now drive Steriline Asia to expand further; it will soon be able to rely on new resources and on a warehouse opening on site, while also benefitting from collaborations with new partner companies for the production of components and format parts.

“Our closeness to the Indian market and all our efforts are leading us towards a new goal, which we expect to reach in 2026, namely double-digit installations completed in one year,” says Filippo Parini, head of Sales India for Steriline. “This would be a great achievement and a record for Steriline in Asia.”

Steriline was founded in 1989 in the Lake Como area (Italy), where its headquarters and manufacturing facilities are still based. Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for aseptic processing. 

These applications are consistent with vials, bottles, vials, cartridges and syringes and can handle toxic or non-toxic products in both liquid and powder form. Steriline’s complete lines include equipment ranging from washing machines, depyrogenation tunnels, filling and capping machines, to external decontamination machines and barrier systems such as LAF, oRABS, cRABS and isolators.

Packaging South Asia — An authentic, impactful, and influential 20-year-old !

An English-language packaging industry B2B platform in print and web, Packaging South Asia is in its 20th year of publication. Without claims about being the best, most widely read, or most influential, our Google analytics have doubled in the past year. If you are interested in impactfully targeting the Indian and South Asian markets to sell equipment, technology, software, and consumables, we can help.

We can assess your potential and addressable markets in light of the competition with research and discuss marketing, communication, and sales strategies for market entry and growth. [www.ippstar.org]

With a strategy and budget for targeted marketing, you can discuss optimal use of our hybrid print, web, video, and social media channels for brand recognition linked to market relevance. Our platforms and channels are differentiated by hands-on domain practice and experience. We understand of business and financials, and our team, including some of the best globally recognized technical writers, is ready to meet you and your customers for content.

Get our 2026 media kit and recalibrate your role in this dynamic market. Enhance visibility and relevance to turn potential customers into success. Ask for a sample copy of our print monthly or our two weekly packaging eZines.

For editorial info@ippgroup.in — for advertisement ads1@ippgroup.in and for subscriptions subscription@ippgroup.in

Naresh Khanna – 12 January 2026

Subscribe Now

NEWSLETTER

Subscribe to our Newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here